ID   NCC-GCTB10-C1
AC   CVCL_E6MF
RX   PubMed=39653987;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: ~41.7 hours (PubMed=39653987).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Gly35Trp (c.103G>T) (G34W); Zygosity=Heterozygous (PubMed=39653987).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Bone, proximal tibia; UBERON=UBERON_0008772.
ST   Source(s): PubMed=39653987
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 10,14
ST   D21S11: 30,31.2
ST   D5S818: 9,10
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C4304; Malignancy in giant cell tumor of bone
DI   ORDO; Orphanet_363976; Giant cell tumor of bone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
RX   PubMed=39653987; DOI=10.1007/s13577-024-01153-z;
RA   Adachi Y., Noguchi R., Osaki J., Ono T., Akiyama T., Kondo H.,
RA   Kobayashi E., Kojima N., Yoshida A., Yokoo H., Kawai A., Kondo T.;
RT   "Establishment and characterization of NCC-GCTB10-C1: a novel cell
RT   line derived from a patient with recurrent giant cell tumor of bone.";
RL   Hum. Cell 38:29.1-29.11(2025).
//